header banner
SOCIETY

Department of Drug Administration issues notice regarding drug recall

The DDA on Friday announced the need to return the drug 'Levoflox-500' tablets. The drug, identified by batch number 'BB-24001', is to be withdrawn from the market.
alt=
By REPUBLICA

KATHMANDU, Jan 2: The Department of Drug Administration (DDA) has released a notice concerning the recall of certain medications. The DDA on Friday announced the need to return the drug 'Levoflox-500' tablets. 



The drug, identified by batch number 'BB-24001', is to be withdrawn from the market. Manufactured by Magnus Pharma Pvt. Ltd., this medication is intended to prevent bacterial infections. The department has urged all individuals not to recommend, sell, distribute, or use the drug associated with the specified batch number. 


Related story

Department of Drug Administration directed to inspect drug stor...


After conducting sample collections and tests of marketed drugs at the National Drug Laboratory, it was determined that the drugs from the specified batch produced by the manufacturer did not meet quality standards. 


Consequently, in accordance with Section 14 of the Drug Act, 2035 BS, the sale and distribution of these drugs have been suspended, and they must be promptly recalled from the market, with records submitted to the DDA. 


The notice has been issued to inform the relevant industry and their representatives.


 


 

Related Stories
POLITICS

SC issues show cause notice on the writ petition r...

Supreme-Court-Bulding_20190916072158.jpg
ECONOMY

DoR issues public notice not to build new structur...

DepartmentofRoads_20230813171033.jpg
SOCIETY

DDA bans production of 10 types of medicines

DDA_20231213105843.jpg
SOCIETY

NBA expresses concern over govt’s decision to reca...

kB0Fnna9TA0dNkV5iKPiuS6A9xJfqFAoaJeB6UYK.jpg
ECONOMY

DDA preparing to give clean chit to Sanghai Group...

departmentofdrug_20230207180106.jpg